Provider review

bmiMD review: pricing, pharmacy, and evidence status

Released: · Last reviewed: · By Dr. Parmis

bmiMD offers GLP-1 medications through telehealth. Every price, credential and pharmacy claim below is labeled by evidence status and read date.

bmiMD's lowest price on file is $119/month (Monthly (carried; not re-read)), read September 12, 2026 on its own page. It does not name a dispensing pharmacy. It is not scored in the November 20, 2026 re-score because its pages could not be read.

Rank and score

bmiMD is not scored in the November 20, 2026 re-score: bmimd.com returned HTTP 403 in the November 20, 2026 portfolio re-read; its page was readable on November 21 and will be scored on the next re-read. Giving it points, or zeros, for pages we could not read would misstate what it discloses. See the methodology.

Pricing by plan

Prices as stated on the provider's own published page unless marked otherwise. "Provider reported" means GLP Ranked has not independently reproduced the figure — see evidence status per row.
MedicationFormulationPlanPriceSourceEvidence
tirzepatidecompounded microdosemonth-to-month$349/monot published · read 2026-07-06Unverified — no source on file
tirzepatidecompounded injectableMonthly (carried; not re-read)$179/moprovider page · read 2026-09-12Provider reported
semaglutidecompounded injectableMonthly (carried; not re-read)$119/moprovider page · read 2026-09-12Provider reported

"Provider reported" means the figure comes from the company's own site or intake flow and has not been independently corroborated by GLP Ranked.

Clinical model

Not disclosed on the pages we could read. We could not identify the medical group or prescriber entity this company uses.

Accreditation: we have not verified any accreditation or certification claim for bmiMD against the issuing body. If a program cites one (for example LegitScript), check the issuer's public lookup before you rely on it.

Pharmacy & compliance

Not publicly disclosed — the fulfilling pharmacy or outsourcing facility is not named. Pharmacy transparency is worth 15 of 100 points under our v4.1 rubric.

State availability

State-by-state availability is not independently verified.

Who this suits — and who it doesn't

bmiMD may suit patients who want a standard-dose program and are comfortable proceeding without a named dispensing pharmacy disclosed up front.It is a weaker fit for patients who need written proof of pharmacy accreditation before paying; ask the company for it.

Terms to check before you pay: cancellation and refund terms could not be read in this re-score; published support response times: not published.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Sources

  1. FDA: Warning letters index (searched for this program) — Regulator database, captured 2026-11-20
  2. FDA: Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (content current October 1, 2026) — Regulator page, captured 2026-11-20
  3. FDA: Compounding: Inspections, Recalls, and other Actions (content current October 22, 2026) — Regulator list, captured 2026-11-21

Cite this page

GLP Ranked. "bmiMD review: pricing, pharmacy, and evidence status." https://glpranked.com/providers/bmimd/

GLP Ranked. "bmiMD review: pricing, pharmacy, and evidence status." https://glpranked.com/providers/bmimd/